Adv Urol. 2009;231861. doi: 10.1155/2009/231861. Epub 2009 Jul 20.
Bladder tumor in women with microscopic hematuria: an Iranian experience and a review of the literature.
Advances in urology
Shahin Abbaszadeh, Saeed Taheri, Mohammad Hossein Nourbala
Affiliations
Affiliations
- Dr. Taheri Medical Research Group, Baqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah Hospital, Mullasadra Ave, Tehran 1435915371, Iran.
PMID: 19639044
PMCID: PMC2715568 DOI: 10.1155/2009/231861
Abstract
AIM: In this study we report our experience with microhematuria and its relation with bladder tumors in Iranian women.
MATERIALS AND METHODS: Overall 249 women were evaluated. Microscopic hematuria was defined as three or more red blood cells per high-power field on at least two different occasions. Patients with a history of gross hematuria or coagulation disorders, having organic diseases, urinary stones, urinary tract infections, nephrological diseases, and local lesions such as urethral caruncle were excluded from the study population. Final diagnosis of malignant tumors was done with cystoscopy and biopsy specimen pathological assessment in all cases.
RESULTS: Age for the study population was 49.7 +/- 11.8 years. 95 (38%) of patients were identified during routine check up and presenting symptoms in other patients were frequency, dysuria, stress urge incontinence, urge incontinence, feeling of incomplete urine emptying, and flunk pain, respectively. Finally, 7 (2.8%) of study subjects were confirmed as having bladder tumors. One of tumor cases was diagnosed 24 months after initial assessments. Patients with bladder tumor were significantly older; more frequently had diverticulum in their bladder wall (P < .05).
CONCLUSION: Female microscopic hematuria is relevant and deserves evaluations, especially in elderly patients. Patients whose reason for microhematuria would not be diagnosed at the initial evaluations should be followed.
References
- N Engl J Med. 2003 Jun 5;348(23):2330-8 - PubMed
- J Urol. 1990 Jul;144(1):99-101 - PubMed
- Urology. 2001 May;57(5):889-94 - PubMed
- Scand J Urol Nephrol. 2001 Dec;35(6):497-501 - PubMed
- J Urol. 1987 Nov;138(5):1189-90 - PubMed
- Urology. 1995 Oct;46(4):484-9 - PubMed
- BMJ. 2003 Apr 12;326(7393):813-5 - PubMed
- Cleve Clin J Med. 2007 May;74 Suppl 3:S6-14 - PubMed
- Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):439-43 - PubMed
- QJM. 2004 Nov;97(11):739-45 - PubMed
- J Urol. 1995 Jul;154(1):57-61 - PubMed
- BJU Int. 2002 Sep;90(4):355-7 - PubMed
- JAMA. 1989 Sep 1;262(9):1214-9 - PubMed
- J Urol. 1988 May;139(5):1002-6 - PubMed
- Urology. 1986 Dec;28(6):453-5 - PubMed
- Am Fam Physician. 2001 Mar 15;63(6):1145-54 - PubMed
- Emerg Med Clin North Am. 2001 Aug;19(3):621-32 - PubMed
- Arch Intern Med. 1988 Dec;148(12):2629-32 - PubMed
- Am Fam Physician. 2000 May 1;61(9):2611 - PubMed
- JAMA. 1986 Jul 11;256(2):224-9 - PubMed
- J Urol. 1980 Sep;124(3):389-91 - PubMed
- Bangladesh Med Res Counc Bull. 2000 Dec;26(3):92-5 - PubMed
- J Urol. 2000 Feb;163(2):524-7 - PubMed
- JAMA. 1990 May 9;263(18):2475-80 - PubMed
Publication Types